Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Gelteq Ltd GELS

Healthcare Biotechnology
Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its... see more

Recent & Breaking News (NDAQ:GELS)

    Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform

    GlobeNewswire October 23, 2025

    Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound

    GlobeNewswire October 9, 2025

    Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner

    GlobeNewswire September 12, 2025

    Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market

    GlobeNewswire September 5, 2025

    Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs

    ACCESS Newswire September 4, 2025

    Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities

    GlobeNewswire July 17, 2025

    Gelteq Expands U.S. Operations with Healthy Extracts Inc. as North American Fulfillment Partner

    GlobeNewswire June 10, 2025

    Gelteq's Sportsgel Brand Named Official Sponsor of the Professional Pickleball Tour and League of Australia and New Zealand

    GlobeNewswire February 27, 2025

    Gelteq Launches SportsGel Brand and Signs Distribution Agreement with E-Commerce Solutions Company in Asia-Pacific Region, WPIC

    GlobeNewswire February 4, 2025

    Gelteq Appoints Matthew Jones as Head of Sports Performance

    GlobeNewswire January 24, 2025

    Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology

    GlobeNewswire December 19, 2024

    Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug

    GlobeNewswire December 17, 2024

    Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference

    GlobeNewswire December 9, 2024

    Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand

    GlobeNewswire December 2, 2024

    Gelteq Announces 400,000 Units Enter into Production in November 2024

    GlobeNewswire November 26, 2024

    Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business

    GlobeNewswire November 12, 2024

    Gelteq Limited Closes US$5.2 Million Initial Public Offering

    GlobeNewswire October 30, 2024